Ted M. Ross

12.7k total citations · 1 hit paper
269 papers, 8.2k citations indexed

About

Ted M. Ross is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Ted M. Ross has authored 269 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Epidemiology, 127 papers in Immunology and 63 papers in Infectious Diseases. Recurrent topics in Ted M. Ross's work include Influenza Virus Research Studies (185 papers), Respiratory viral infections research (108 papers) and Immune Response and Inflammation (51 papers). Ted M. Ross is often cited by papers focused on Influenza Virus Research Studies (185 papers), Respiratory viral infections research (108 papers) and Immune Response and Inflammation (51 papers). Ted M. Ross collaborates with scholars based in United States, Canada and France. Ted M. Ross's co-authors include Franklin R. Toapanta, Donald M. Carter, James D. Allen, Corey J. Crevar, Brendan M. Giles, Greg A. Kirchenbaum, Rick A. Bright, Giuseppe A. Sautto, Harriet L. Robinson and Ivette A. Nuñez and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Ted M. Ross

254 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

2021 183 citations Emma S. Winkler, Pavlo Gilchuk et al. Cell profile →

Peers

Countries citing papers authored by Ted M. Ross

Since Specialization

Citations

This map shows the geographic impact of Ted M. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted M. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted M. Ross more than expected).

Fields of papers citing papers by Ted M. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted M. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted M. Ross. The network helps show where Ted M. Ross may publish in the future.

Co-authorship network of co-authors of Ted M. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Ted M. Ross. A scholar is included among the top collaborators of Ted M. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted M. Ross. Ted M. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elicitation of protective immune responses against influenza a viruses in elderly ferrets by adjuvanted recombinant universal influenza hemagglutinin vaccines 2025 ·Immunity & Ageing ·Xiaojian Zhang, (unknown), Ted M. Ross	0
2	Elicitation of neutralizing antibodies and IgG4 subclass switching following booster vaccination with ancestral COVID-19 mRNA vaccines does not reduce breakthrough infections 2025 ·Human Vaccines & Immunotherapeutics ·Engin Berber, (unknown), (unknown), (unknown), Ted M. Ross	1
3	COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes 2024 ·Virology ·(unknown), Ted M. Ross	1
4	Pre-existing immunity to influenza aids ferrets in developing stronger and broader H3 vaccine-induced antibody responses 2024 ·Vaccine ·Yang Ge, Yao Lu, James D. Allen, Tal Einav, (unknown), Fengwei Bai, Andreas Handel, Ted M. Ross, Ye Shen	1
5	Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines 2024 ·Vaccines ·Pedro L. Sánchez, (unknown), (unknown), Nikolai Petrovsky, Ted M. Ross	1
6	mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020 2024 ·Frontiers in Immunology ·James D. Allen, Ted M. Ross	7
7	Structural basis for the broad antigenicity of the computationally optimized influenza hemagglutinin X6 2024 ·Structure ·(unknown), John V. Dzimianski, Meng Yang, Jan Abendroth, Giuseppe A. Sautto, Ted M. Ross, Rebecca M. DuBois, Thomas E. Edwards, Jarrod J. Mousa	1
8	Interferon as an immunoadjuvant to enhance antibodies following influenza B infection and vaccination in ferrets 2024 ·npj Vaccines ·Thomas Rowe, Ashley A. Fletcher, Pavel Svoboda, Jan Pohl, Yasuko Hatta, Gabriela Jasso, David E. Wentworth, Ted M. Ross	0
9	Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines 2023 ·Viruses ·(unknown), (unknown), (unknown), (unknown), Ted M. Ross, Jarrod J. Mousa	4
10	An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge 2023 ·Vaccine ·Yoshikazu Honda‐Okubo, Lei Li, (unknown), (unknown), Elizabeth W. Howerth, (unknown), Ted M. Ross, Nikolai Petrovsky	10
11	Zinc Carnosine Metal–Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability 2023 ·Molecular Pharmaceutics ·(unknown), Liubov M. Lifshits, Cole J. Batty, Michael A. Carlock, Ted M. Ross, Jarrod J. Mousa, Eric M. Bachelder, Kristy M. Ainslie	6
12	H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans 2022 ·Influenza and Other Respiratory Viruses ·(unknown), Leonard Moise, (unknown), Constantinos S. Kyriakis, Andrés H. Gutiérrez, Ted M. Ross, Justin Bahl, Anne S. De Groot	1
13	Sex disparities in influenza: A multiscale network analysis 2022 ·iScience ·Chang Wang, Lauren Lashua, Chalise E. Carter, Scott K. Johnson, Minghui Wang, Ted M. Ross, Elodie Ghedin, Bin Zhang, Christian V. Forst	14
14	Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection breakdown → 2021 ·Cell ·Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Adam L. Bailey, Rita E. Chen, Zhenlu Chong, Seth J. Zost, Hyesun Jang, Ying Huang, James D. Allen, James Brett Case, Rachel E. Sutton, Robert H. Carnahan, Tamarand L. Darling, Adrianus C. M. Boon, Matthias Mack, Richard D. Head, Ted M. Ross, James E. Crowe, Michael Diamond	183
15	Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity 2020 ·Proceedings of the National Academy of Sciences ·Daniel W. Heindel, (unknown), Yue Zhang, Brian Kasper, (unknown), Christopher A. Vaiana, Stephanie J. Bissel, Chalise E. Carter, Alyson A. Kelvin, Mohamed Elaish, Joaquín López-Orozco, Bin Zhang, Bin Zhou, Tsui-Wen Chou, Lauren Lashua, Tom C. Hobman, Ted M. Ross, Elodie Ghedin, Lara K. Mahal	39
16	Infection of Ferrets with Influenza Virus Elicits a Light Chain–Biased Antibody Response against Hemagglutinin 2017 ·The Journal of Immunology ·Greg A. Kirchenbaum, James D. Allen, Thomas Layman, Giuseppe A. Sautto, Ted M. Ross	22
17	C3d regulates immune checkpoint blockade and enhances antitumor immunity 2017 ·JCI Insight ·Jeffrey L. Platt, Inês Pires da Silva, Samuel J. Balin, Adam R. Lefferts, Evan A. Farkash, Ted M. Ross, Michael C. Carroll, Marília Cascalho	21
18	COBRA-Based Dengue Tetravalent Vaccine Elicits Neutralizing Antibodies Against All Four Dengue Serotypes 2014 ·Ted M. Ross, Xianchun Tang, (unknown), David Olagnier, Greg A. Kirchenbaum, Jared Evans, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
19	Influenza Virus Infection Elicits Protective Antibodies and T Cells Specific for Host Cell Antigens Also Expressed as Tumor-Associated Antigens: A New View of Cancer Immunosurveillance 2013 ·Cancer Immunology Research ·(unknown), Pamela Beatty, Phu T. Van, Ted M. Ross, Jonathan S. Minden, Olivera J. Finn	31
20	Immune history shapes specificity of pandemic H1N1 influenza antibody responses 2013 ·The Journal of Experimental Medicine ·Yang Li, (unknown), David Bostick, (unknown), Jonathan J. Madara, Susanne L. Linderman, Qin Liu, Donald M. Carter, Jens Wrammert, Susanna Esposito, Nicola Principi, Joshua B. Plotkin, Ted M. Ross, Rafi Ahmed, Patrick C. Wilson, Scott E. Hensley	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact